Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CTNNA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTCF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SART1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF21A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
P2RY8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
GPHN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NGRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GADD45B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCYL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on